NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 213 filers reported holding NEVRO CORP in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $26,262,000 | -9.1% | 563,560 | -14.5% | 0.95% | -13.9% |
Q2 2022 | $28,902,000 | -38.5% | 659,410 | +1.5% | 1.10% | -37.2% |
Q1 2022 | $46,979,000 | +19.4% | 649,513 | +33.9% | 1.76% | +31.2% |
Q4 2021 | $39,330,000 | -14.0% | 485,135 | +23.5% | 1.34% | -0.4% |
Q3 2021 | $45,712,000 | -34.1% | 392,786 | -6.2% | 1.34% | -38.2% |
Q2 2021 | $69,407,000 | +11.8% | 418,645 | -5.9% | 2.18% | +14.8% |
Q1 2021 | $62,060,000 | +14.9% | 444,877 | +42.6% | 1.90% | -0.3% |
Q4 2020 | $53,997,000 | +21.8% | 311,940 | -2.0% | 1.90% | -7.3% |
Q3 2020 | $44,330,000 | +256.2% | 318,232 | +205.5% | 2.05% | +217.3% |
Q2 2020 | $12,446,000 | -81.7% | 104,180 | -81.9% | 0.65% | -80.0% |
Q4 2019 | $67,840,000 | +99.1% | 577,163 | +45.6% | 3.23% | +221.2% |
Q3 2019 | $34,067,000 | -36.8% | 396,270 | -52.3% | 1.01% | -1.7% |
Q2 2019 | $53,863,000 | +19.5% | 830,834 | +15.2% | 1.02% | +2.7% |
Q1 2019 | $45,084,000 | +108.5% | 721,229 | +29.7% | 1.00% | +73.2% |
Q4 2018 | $21,627,000 | +97.5% | 556,095 | +376.0% | 0.58% | +109.9% |
Q1 2017 | $10,948,000 | – | 116,836 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |